Why Sorrento Therapeutics, Novavax, Moderna, and Other Coronavirus Stocks Plunged TodayThe Motley Fool • 08/11/20
Stock Markets Take Late-Day Hit; Inovio, Novavax Plunge on Coronavirus Vaccine ConcernsThe Motley Fool • 08/11/20
Novavax Ready to Produce Nearly 3 Billion Coronavirus Vaccine Doses (With a Little Help From Friends)The Motley Fool • 08/11/20
After Mixed Q2 Report, Novavax Analyst Details Possible Coronavirus Vaccine CatalystsBenzinga • 08/11/20
Novavax, Inc. (NVAX) CEO Stan Erck on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/11/20
T Cell Responses To Coronavirus Vaccines Are In The Interest Of National SecuritySeeking Alpha • 08/10/20
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in JapanGlobeNewsWire • 08/07/20
Novavax and Serum Institute of India Announce Development and Commercial CollaborationGlobeNewsWire • 08/06/20
Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020GlobeNewsWire • 08/06/20
Novavax Inks Deal With India's Serum Institute To Make Coronavirus Vaccine Available In Low, Middle Income CountriesBenzinga • 08/06/20
Novavax Stock Spirals To Record High On Positive Coronavirus Vaccine DataInvestors Business Daily • 08/05/20